Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Melot

Showing results (1-10 of 109) with videos related to

Pageof 11
Sort By:
Revue Medicale De Bruxelles|May 20, 2017
C Melot
Revue Des Maladies Respiratoires|January 1, 1986
[Respiratory exchanges]C Melot, A Frans
ACS Applied Materials & Interfaces|July 24, 2014
Preface: Forum on new materials and approaches for electrochemical storageYiying Wu, Brent C Melot
Revue Medicale De Bruxelles|November 1, 1980
[Treatment of hypertension by labetalol (author's transl)]J Sternon, C Melot, E Contu
Accounts of Chemical Research|January 4, 2013
Design and preparation of materials for advanced electrochemical storageBrent C Melot, J-M Tarascon
Metabolism: Clinical and Experimental|April 1, 1993
Glucose fluxes and oxidation after an oral glucose load in patients with non-insulin-dependent diabetes mellitus of variable severityF Féry, C Melot, E O Balasse
Inorganic Chemistry|April 22, 2010
Structure and magnetic field-induced transition in a one-dimensional hybrid inorganic-organic chain system, Co2(4,4'-bpy)(tfhba)2.4,4'-bpy (4,4'-bpy = 4,4'-bipyridine; tfhba = 2,3,5,6-tetrafluoro-4-hydroxybenzoate)Zeric Hulvey, Brent C Melot, Anthony K Cheetham
European Journal of Respiratory Diseases|July 1, 1982
Ondine's curse. Report of a patient treated with almitrine, a new respiratory stimulantN Naeije, C Melot, R Naeije, et al.
Chest|November 1, 1981
Hypoxic pulmonary vasoconstriction in liver cirrhosisR Naeije, R Hallemans, P Mols, et al.
Chest|May 1, 1987
Reduction in pulmonary hypertension and in airway resistances by enoximone (MDL 17,043) in decompensated COPDM Leeman, P Lejeune, C Melot, et al.
Pageof 11

Showing results (1-10 of 109) with videos related to

Sort By:
Pageof 11
Revue Medicale De Bruxelles|May 20, 2017
C Melot
Revue Des Maladies Respiratoires|January 1, 1986
[Respiratory exchanges]C Melot, A Frans
ACS Applied Materials & Interfaces|July 24, 2014
Preface: Forum on new materials and approaches for electrochemical storageYiying Wu, Brent C Melot
Revue Medicale De Bruxelles|November 1, 1980
[Treatment of hypertension by labetalol (author's transl)]J Sternon, C Melot, E Contu
Accounts of Chemical Research|January 4, 2013
Design and preparation of materials for advanced electrochemical storageBrent C Melot, J-M Tarascon
Metabolism: Clinical and Experimental|April 1, 1993
Glucose fluxes and oxidation after an oral glucose load in patients with non-insulin-dependent diabetes mellitus of variable severityF Féry, C Melot, E O Balasse
Inorganic Chemistry|April 22, 2010
Structure and magnetic field-induced transition in a one-dimensional hybrid inorganic-organic chain system, Co2(4,4'-bpy)(tfhba)2.4,4'-bpy (4,4'-bpy = 4,4'-bipyridine; tfhba = 2,3,5,6-tetrafluoro-4-hydroxybenzoate)Zeric Hulvey, Brent C Melot, Anthony K Cheetham
European Journal of Respiratory Diseases|July 1, 1982
Ondine's curse. Report of a patient treated with almitrine, a new respiratory stimulantN Naeije, C Melot, R Naeije, et al.
Chest|November 1, 1981
Hypoxic pulmonary vasoconstriction in liver cirrhosisR Naeije, R Hallemans, P Mols, et al.
Chest|May 1, 1987
Reduction in pulmonary hypertension and in airway resistances by enoximone (MDL 17,043) in decompensated COPDM Leeman, P Lejeune, C Melot, et al.
Pageof 11